Hospitals | December 16, 2025
KIMS Hospital Bengaluru commences operations at PES University campus
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
WINREVAIR is currently the first and only activin signalling inhibitor approved for PAH across all 27 EU member states
The new centre brings advanced corneal procedures pioneered in India
The approval follows strong results from Roche’s phase II NOBILITY and phase III REGENCY studies
Columvi combined with gemcitabine and oxaliplatin dramatically extends survival in people with relapsed or refractory diffuse large B-cell lymphoma
Fresh Phase 1b/2a data highlight the strength of the iberdomide + daratumumab + dexamethasone combination in transplant-deferred or ineligible NDMM
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
The therapy -- Ryoncil (remestemcel-L-rknd) -- will be tested in adults with severe steroid-refractory acute graft-versus-host disease
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
Subscribe To Our Newsletter & Stay Updated
